Literature DB >> 18283480

TAP deficiency syndrome: chronic rhinosinusitis and conductive hearing loss.

Marco Caversaccio1, Harald Marcel Bonél, Rachel Carter, Anthony P Williams, Stephan D Gadola.   

Abstract

Nose-ear-throat manifestations of immunodeficiency disorders represent a diagnostic challenge for clinicians as these diseases often constitute the initial sign for connective disorders or autoimmune disease. The history of chronic rhinosinusitis and conductive hearing loss is often non specific. Therefore attention to an HLA class I deficiency must be considered if the disease has not been diagnosed on routine examination. One of the syndromes is due to a defective TAP complex, the peptide transporter complex associated with antigen presentation. Herein, we report two sisters with TAP-deficiency. The treatment of choice for TAP-deficient patients is conservative.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18283480     DOI: 10.1007/s00405-008-0610-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  8 in total

Review 1.  Management of the ear, nose, and throat manifestations of Wegener granulomatosis: an otorhinolaryngologist's perspective.

Authors:  N Rasmussen
Journal:  Curr Opin Rheumatol       Date:  2001-01       Impact factor: 5.006

Review 2.  TAP deficiency syndrome.

Authors:  S D Gadola; H T Moins-Teisserenc; J Trowsdale; W L Gross; V Cerundolo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Association of class I major histocompatibility heavy and light chains induced by viral peptides.

Authors:  A Townsend; C Ohlén; J Bastin; H G Ljunggren; L Foster; K Kärre
Journal:  Nature       Date:  1989-08-10       Impact factor: 49.962

Review 4.  Mechanisms of MHC class I--restricted antigen processing.

Authors:  E Pamer; P Cresswell
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

Review 5.  Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors.

Authors:  M Colonna
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

6.  Association of a syndrome resembling Wegener's granulomatosis with low surface expression of HLA class-I molecules.

Authors:  H T Moins-Teisserenc; S D Gadola; M Cella; P R Dunbar; A Exley; N Blake; C Baykal; J Lambert; P Bigliardi; M Willemsen; M Jones; S Buechner; M Colonna; W L Gross; V Cerundolo; C Baycal
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

7.  HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1.

Authors:  H de la Salle; J Zimmer; D Fricker; C Angenieux; J P Cazenave; M Okubo; H Maeda; A Plebani; M M Tongio; A Dormoy; D Hanau
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

Review 8.  Ear-nose-throat manifestations of autoimmune rheumatic diseases.

Authors:  E D Papadimitraki; D E Kyrmizakis; I Kritikos; D T Boumpas
Journal:  Clin Exp Rheumatol       Date:  2004 Jul-Aug       Impact factor: 4.473

  8 in total
  4 in total

1.  Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosis.

Authors:  Thomas P Hofer; Marion Frankenberger; Irene Heimbeck; Dorothe Burggraf; Matthias Wjst; Adam K A Wright; Maria Kerscher; Susanne Nährig; Rudolf M Huber; Rainald Fischer; Loems Ziegler-Heitbrock
Journal:  J Mol Med (Berl)       Date:  2014-08-23       Impact factor: 4.599

Review 2.  A novel approach to analyze gene expression data demonstrates that the DeltaF508 mutation in CFTR downregulates the antigen presentation pathway.

Authors:  Thomas H Hampton; Bruce A Stanton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-31       Impact factor: 5.464

Review 3.  Know Thyself: NK-Cell Inhibitory Receptors Prompt Self-Tolerance, Education, and Viral Control.

Authors:  William T Nash; Jeffrey Teoh; Hairong Wei; Awndre Gamache; Michael G Brown
Journal:  Front Immunol       Date:  2014-04-16       Impact factor: 7.561

4.  Polyclonal Expansion of NKG2C(+) NK Cells in TAP-Deficient Patients.

Authors:  Vivien Béziat; Marwan Sleiman; Jodie P Goodridge; Mari Kaarbø; Lisa L Liu; Halvor Rollag; Hans-Gustaf Ljunggren; Jacques Zimmer; Karl-Johan Malmberg
Journal:  Front Immunol       Date:  2015-10-06       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.